-
公开(公告)号:DE3808353A1
公开(公告)日:1989-09-21
申请号:DE3808353
申请日:1988-03-12
Applicant: BASF AG
Inventor: DAUM LOTHAR DR , DOERPER THOMAS DR , GEISS KARL-HEINZ DR , HERR DIETER DR , SCHLICK ERICH DR
IPC: C12N9/99 , A61K31/505 , A61K31/52 , A61K31/715 , A61K38/00 , A61K38/19 , A61K38/21 , A61K39/395 , A61K45/06 , A61P31/12 , A61P37/00 , A61P43/00
-
公开(公告)号:DE3782549D1
公开(公告)日:1992-12-17
申请号:DE3782549
申请日:1987-06-20
Applicant: BASF AG
Inventor: SCHOLLMEIER KLAUS DR , MOELLER ACHIM DR , KOERWER WOLFGANG DR , DOERPER THOMAS DR , HILLEN HEINZ DR , DAUM LOTHAR DR , EMLING FRANZ DR , KEILHAUER GERHARD DR
IPC: C07K14/52 , A61K38/00 , A61P35/00 , C07K14/00 , C07K14/525 , C12N15/00 , C12N15/09 , C12P21/02 , C12R1/19 , A61K37/02 , C07K15/00
Abstract: (I) and their allelic variations and mutagenically produced derivs. with lymphotoxin or lymphotoxin-like activity, as well as derivs. having an N-terminal immunogenic peptide sequence, are new. (I) is X-Leu-Lys-Pro-Ala-Ala-His-Leu-Ile -Gly-Asp-Pro-Ser-Lys-Gln-Asn-Ser-Leu- Leu-Trp-Arg-Ala-Asn-Thr-Asp-Arg-Ala-Phe-Leu-Gln-Asp-Gly-Phe-Ser-L- eu-Ser-Asn-Asn-Ser-Leu-Leu -Val-Pro-Thr-Ser-Gly-Ile -Tyr-Phe-Val-Tyr-Ser-Gln- -Val-Val-Phe-Ser-Gly-Lys-Ala-Tyr-Ser-Pro-Lys-Ala-Thr- Ser-Ser-Pro-Leu Tyr-Leu-Ala-His-Glu-Val -Gln- Leu-Phe-Ser--Ser-Gln-Tyr-Pro-Phe-His-Val-Pro- Leu-Leu-Ser-Ser-Gln -Lys-Met-Val-Tyr-Pro-Gly- Leu-Gln-Glu-Pro -Trp-Leu-His-Ser-Met-Tyr-His-Gly -Ala-Ala-Phe-Gln-Leu-Thr-Gln-Gly-Asp- Gln-Leu-Ser-Thr -His-Thr-Asp-Gly-Ile-Pro-His-Leu -Val-Leu-Ser-Pro Ser-Thr-Val-Phe-Phe-Gly -Ala-Phe-Ala-Leu, where X = Thr, Ser-Thr, Met-Ser-Thr, Ala-Thr or Ala-Ser-Thr. DNA sequences coding for the polypeptides are also new.
-
公开(公告)号:DE3922089A1
公开(公告)日:1990-12-13
申请号:DE3922089
申请日:1989-07-05
Applicant: BASF AG
Inventor: LEMAIRE HANS-GEORG DR , HILLEN HEINZ DR , MOELLER ACHIM DR , DAUM LOTHAR DR , DOERPER THOMAS DR , SUBKOWSKI THOMAS DR
IPC: A61K35/22 , A61K38/00 , A61K38/17 , A61K38/19 , A61P7/00 , A61P7/02 , A61P7/04 , A61P11/00 , A61P19/00 , A61P19/02 , A61P19/08 , A61P25/00 , A61P29/00 , A61P31/04 , A61P37/00 , A61P37/02 , A61P37/08 , A61P43/00 , C07K1/18 , C07K1/22 , C07K7/08 , C07K14/00 , C07K14/435 , C07K14/47 , C07K14/525 , C07K14/715 , C07K16/18
Abstract: Novel proteins have a molecular weight of approximately 42.000 daltons and the amino acid sequence Xaa Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr Cys Arg Leu Arg Glu on their terminal N, where X denotes a hydrogen atom, a phenylalanine (Phe) residue or the amino acid sequences Ala Phe, Val Ala Phe, Gln Val Ala Phe, Ala Gln Val Ala Phe, Pro Ala Gln Val Ala Phe or Leu Pro Ala Gln Val Ala Phe. These proteins have a therapeutic effect.
-
公开(公告)号:DE3823805A1
公开(公告)日:1990-01-18
申请号:DE3823805
申请日:1988-07-14
Applicant: BASF AG
-
公开(公告)号:DE3735917A1
公开(公告)日:1989-05-03
申请号:DE3735917
申请日:1987-10-23
Applicant: BASF AG
Inventor: KOERWER WOLFGANG DR , KURFUERST MANFRED DR , BALDINGER VERENA DR , DOERPER THOMAS DR
-
公开(公告)号:DE3716513A1
公开(公告)日:1988-11-24
申请号:DE3716513
申请日:1987-05-16
Applicant: BASF AG
Inventor: DOERPER THOMAS DR , MOELLER ACHIM DR , HILLEN HEINZ DR , DAUM LOTHAR DR , KEILHAUER GERHARD DR , EMLING FRANZ DR
IPC: C12N15/09 , A61K38/00 , A61P35/00 , C07K1/20 , C07K14/00 , C07K14/52 , C07K14/525 , C07K14/78 , C07K19/00 , C12P21/02 , C12R1/19 , C07K13/00 , C07H21/04
Abstract: Tumor necrosis factor (TNF) produced from the TNF molecule by modification at the amino terminus are prepared as described and are suitable for controlling diseases.
-
-
-
-
-